April 2025

134 Articles

No Section

The role of achieving blood pressure targets in renal protection: Insights from the VALUE trial

12 April 2025
Author(s): Yong Wang, Mingzhu Jiang, Wei Zhou

We have read with great interest the article by Olsen et al. on the VALUE trial [1], which investigated the comparative effectiveness of valsartan versus amlodipine in reducing the incidence of end-... more

Demographic features in patients with acute mountain sickness

28 March 2025
Author(s): Haitong Zhao, Hao Wang, Chao Wang, Lei Chen, Fengming Luo

Dear editor,

Chronicity of disease mandates quality-of-life prioritization – a role for digital health and patient-reported outcome measures

10 March 2025
Author(s): Maximilian Boesch, Florent Baty, Sanjay Kalra, Martin H. Brutsche, Frank Rassouli

The field of internal medicine is evolving at unprecedented speed and humankind is steadily growing older. Progress in diagnostics and treatment have improved the prognosis of many diseases and led... more

The Declaration of Helsinki protects clinical trial participants

9 March 2025
Author(s): Rafael Dal-Ré, Søren Holm

Dear Editor,

Some comments on Tecovirimat and mpox

1 March 2025
Author(s): Salvatore Chirumbolo, Umberto Tirelli

The paper by Rizk et al., "Tecovirimat and mpox: A regulatory balancing act between hope, hurdles, and high-risk populations," presents a detailed discussion on the antiviral Tecovirimat (TPOXX) and... more

Hydroxychloroquine use in patients with primary immune thrombocytopenia and antiphospholipid antibodies

13 January 2025
Author(s): Fernando Porto, Artur Saldanha, Erica Okazaki, Paula Villaça, Fernanda A. Orsi

The prevalence of antiphospholipid antibodies (aPL) among patients with immune thrombocytopenia (ITP) is high, at 20 % or higher according to previous studies [1,2].

Clinical Insights

Undiagnosed celiac disease. The conundrum of unveiling the dark side of the moon

1 April 2025
Author(s): Gino Roberto Corazza, Marco Vincenzo Lenti

Celiac disease (CD) is a gluten-induced, inflammatory disease of the small intestine, characterized by high and rising prevalence, huge clinical variability, and increased co-morbidity and mortality... more

The emperor's new clothes and the case of vitamin D and cardiovascular risk. A few thoughts after the guidelines of the American Society of Endocrinology

14 February 2025
Author(s): Claudio Cimminiello

As in the famous Christian Andersen fairy tale, the recent guidelines of the American Society of Endocrinology [1] have confirmed that the king is naked, significantly diminishing the role of... more

Commentary

Lymphangioplasty 4.0 as a therapeutic and educational opportunity for (Lymph)edema

28 March 2025
Author(s): Anna Poretto, Jean Paul Belgrado, Giacomo Rossitto

In this issue of the European Journal of Internal Medicine (EJIM), Mazzolai et al. report on safety and preliminary efficacy of a novel device, that uses subcutaneously implanted catheters to provide... more

Wheels within wheels: Diagnostic and risk modifiers for familial hypercholesterolemia in the community

21 March 2025
Author(s): Seyed Saeed Tamehri Zadeh, Jing Pang, Gerald F Watts

Familial hypercholesterolaemia (FH) is an autosomal dominant condition, marked by elevated plasma concentrations of low-density lipoprotein (LDL)-cholesterol from birth. It confers a substantial risk... more

Acute exacerbation of chronic obstructive pulmonary disease: An underestimated cardiovascular risk factor

11 March 2025
Author(s): Valentine Mismetti, Laurent Bertoletti

Chronic obstructive pulmonary disease (COPD) is a widespread respiratory disease associated with significant morbidity and mortality [1,2]. It ranks among the leading causes of death and is expected... more

Sodium-glucose co-transporter 2 inhibitors in acute heart failure: What are you waiting for?

6 March 2025
Author(s): Herminio Morillas, Josep Comin-Colet

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) were initially discovered as a compound present in roots, leaves and fruits of the apple tree in 1835. However, it was not until the beginning of... more

The prothrombotic effects of Lipoprotein (a) and atherosclerosis

3 March 2025
Author(s): Avishay Elis

Lipoprotein (a) [Lp(a)] is a plasma lipoprotein consisting of a cholesterol-rich LDL particle with one molecule of apolipoprotein B100 and an additional protein which has sequence homology with... more

The misalignment between chronotype and sleep time: Friend or foe?

3 March 2025
Author(s): Eleonora Tobaldini, Angelica Carandina, Nicola Montano

We spend approximately one third of our lifetime in sleep, a complex physiological process which is an established health determinant. In the last decades, it has been demonstrated that reduction of... more

Catheter ablation of atrial fibrillation in older patients: The need for a comprehensive evaluation and management

1 March 2025
Author(s): Mario Bo, Marco Proietti, Roberto Presta

Atrial fibrillation (AF) affects approximately one-third of individuals aged 80 years and over and is associated with a wide range of adverse clinical outcomes, including heart failure (HF), ischemic... more

Redefining thiamine requirements in alcohol use disorder: Aligning treatment with neurocognitive needs

28 February 2025
Author(s): Giovanna Di Sario, Tommaso Dionisi, Giovanni Addolorato

Alcohol Use Disorder (AUD) is a pervasive condition that often presents with marked neurocognitive consequences. From mild executive and memory deficits to severe conditions such as Wernicke–... more

Ischemic heart failure etiology: A misleading definition?

28 February 2025
Author(s): Alexander Schmitt, Michael Behnes, Ibrahim Akin, Tobias Schupp

Heart failure (HF) remains a leading cause of morbidity and mortality despite advances in interventional and pharmacological therapies [1,2]. Beyond the classification based on left ventricular... more

Atrial fibrillation screening: The importance of the patient perspective

24 February 2025
Author(s): Jacopo Francesco Imberti, Davide Antonio Mei, Giuseppe Boriani

Atrial fibrillation (AF) is the most common cardiac arrhythmia, with its prevalence increasing significantly in older adults and individuals with comorbidities [1]. Beyond being a major contributor... more

Internal Medicine Flashcard

A man with chronic progressive mucositis and extensive skin detachment

18 April 2025
Author(s): Shohei Kitayama, Teruhiko Makino, Tadamichi Shimizu

A 62-year-old man was referred to our department with a 6-week history of a progressively worsening rash. Three weeks earlier, he had been admitted for gastric perforation, which was ultimately... more

Omalizumab-associated purpura fulminans

17 April 2025
Author(s): Lan Li, Jie Chen, Kun Yang

A 27-year-old male with chronic urticaria began omalizumab treatment. Before treatment, blood count, coagulation profile, and liver function were normal. After one dose, he developed chest, back, and... more

An umbilical nodule

1 April 2025
Author(s): Gema Castillo-Ruiz, Enrique Rojo-Villardón, Víctor Domínguez-Prieto

A 94-year-old male patient, with previous history of atrioventricular block carrying a pacemaker and right inguinal hernioplasty, and recent history of a painless umbilical nodule suspicious of... more

A man with brown macules on the limbs

28 March 2025
Author(s): Xie He, Shunhong Chen, Ruiting Huang

A 35-year-old man presented with multiple brown macules on the limbs without associated pruritus or pain for 2 years. He observed these changes with no identifiable triggers, and noted a gradual... more

A febrile woman with gas collection in the right upper abdomen

25 March 2025
Author(s): Shinji Yoshida, Junpei Komagamine

A 69-year-old woman with uncontrolled diabetes mellitus presented to the emergency department with a 5-day history of loss of appetite and fever. She reported no sore throat, cough, or abdominal pain... more

Chest pain, inflammatory syndrome and headache

9 March 2025
Author(s): Romain Batton, Ludivine Lebourg, Gaëtan Sauvêtre

A 51-year-old white man presented to the internal medicine department with altered general condition and significant weight loss of 14 kg in 3 months. The main symptom was cervical pain and headache... more

Linear lesions on the chest

3 February 2025
Author(s): Pei-Chun Weng, Pei-Rong Gao

A 70-year-old man with a history of lung adenocarcinoma was admitted to our hospital for chemotherapy. During his hospitalization, eruptive papules with a dermatomal distribution developed on his... more

When skin and lung meet

30 January 2025
Author(s): Sara Piciucchi, Stefano Oldani, Venerino Poletti

A 50-year-old male, heavy smoker (>30 p/Y), presented to E.R. because of chest pain. In his recent clinical history, he had relapsing papular-purpuric small lesions in the limbs, trunk and arms... more

A man with trismus and decubitus ulcers

21 January 2025
Author(s): Rika Okamoto, Masaki Itagane, Mitsuyo Kinjo

A 65-year-old man with a history of binge drinking who had engaged in gardening was brought to our hospital for lethargy. On physical examination, temperature was 35.0 °C, blood pressure was 70/50... more

A 73-year-old man with purpura and fever

15 January 2025
Author(s): Ivânia Soares, Inês Pereira Amaral, Paulo Filipe

A 73-year-old man presented to our dermatology department with a four-week history of palpable purpura on the lower limbs. His medical history included a suspicion of polymyalgia rheumatica based on... more

Invited Review Article

What is new in the management of coeliac disease?

1 February 2025
Author(s): Mohamed G Shiha, David S Sanders

Coeliac disease is a chronic immune-mediated disorder triggered by gluten ingestion in genetically predisposed individuals [1]. It is characterised by immune-mediated inflammation and damage to the... more

Letter to the Editor

Short term variability of peripheral blood eosinophil count in individuals with stable COPD

16 April 2025
Author(s): Claudio Candia, Claudia Merola, Salvatore Fuschillo, Pasquale Ambrosino, Nicolino Ambrosino, Mauro Maniscalco

Chronic obstructive pulmonary disease (COPD) is typically considered a neutrophil-driven inflammatory disease [1], but some individuals, particularly those with frequent exacerbations, show... more

Evidence that adequate vitamin D intake reduces cardiovascular disease risk. Author's reply

15 April 2025
Author(s): Claudio Cimminiello

I thank the colleagues Grant and Boucher for their interest in my clinical insight article [1]. And I also thank them for giving me the opportunity to better clarify a concept already present in my... more

Trends in cardiovascular disease-related mortality among adults with sleep apnea in the United States from 1999-2020

15 April 2025
Author(s): Usama Qamar, Siddharth Agarwal, Maaz Asif, Waleed Qamar, Zain Ul Abideen Asad

Cardiovascular disease-related mortality in adults with comorbid sleep apnea in the United States from 1999 to 2020.

Cardiovascular safety and efficacy of intensive blood pressure control: how low should we go?

14 April 2025
Author(s): Paschalis Karakasis, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis, Ricardo Gómez-Huelgas

Dear Editor,

Excess risk or misestimated baseline? Reconsidering relative survival in the oldest ICU patients

11 April 2025
Author(s): Juan Ye, Kun Huang

We commend Weller et al. for their important and timely contribution, which provides a rigorous and impressively sized analysis of 1076 ICU patients aged 90 years and older, using relative survival... more

Clinical epidemiological characteristics of BRASH syndrome

5 April 2025
Author(s): Junji Kaneyama, Yoshihito Goto, Maki Murata, Tadanobu Irie, Takashi Kawamura

BRASH syndrome—characterized by bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia—has recently been recognized as a distinct clinical entity. This syndrome is... more

Protected discharge and combined interventions: A viable path to reduce hospital readmissions

2 April 2025
Author(s): Gianluca Azzellino, Ernesto Aitella, Mauro Passamonti, Lia Ginaldi, Massimo De Martinis

Hospital readmissions within 30 days continue to be a challenge for healthcare systems, particularly in the case of frail, elderly patients and those with chronic diseases. From international studies... more

Clinical trial landscape for pulmonary arterial hypertension targeted therapy: Beyond vasodilators

1 April 2025
Author(s): Si Pang, Haobo Huang, Hui Luo, Huibing Peng, Mingxing Wu

Pulmonary arterial hypertension (PAH) is a multifaceted and lethal disorder characterized by elevated pulmonary pressures and right ventricular failure, ultimately leading to premature death. With an... more

Thromboembolic and bleeding risks in patients on anticoagulation after noncardiac surgery for malignancy

1 April 2025
Author(s): Satoshi Higuchi, Yusuke Kabeya, Hiroshi Hasegawa, Hideaki Yoshino, Takeaki Matsuda

Dear Editor,

Refining the predictive value of nasal pressure swing in acute hypoxemic respiratory failure management

27 March 2025
Author(s): Danyang Liu

With great interest, we read about the study by Tonelli et al. on the predictive value of nasal pressure swing (Pnose) in assessing respiratory support dependency among patients with acute hypoxemic... more

Efficacy and safety of crinecerfont for the treatment of congenital adrenal hyperplasia

25 March 2025
Author(s): André Saad Cleto, João Matheus Schirlo, Janete Machozeki, Camila Marinelli Martins

Congenital adrenal hyperplasia (CAH) is an autosomal recessive genetic disease that leads to an enzyme deficiency, the main consequence of which is the reduction in the production of cortisol and... more

Clinical factors associated with limited therapeutic implementation in patients with heart failure and reduced ejection fraction hospitalized in internal medicine wards

24 March 2025
Author(s): Arianna Bartoli, Mattia Donadoni, Elisa Ceriani, Chiara Cogliati, DRY-OFF study group

Heart failure (HF) affects over 56 million people globally and accounts for 1–2 % of all hospitalizations in the Western world [1]. Prevalence of HF rises with age, as patients over 70 years of age... more

Accuracy of glomerular filtration rate estimating equations in systemic sclerosis

19 March 2025
Author(s): Chiara Pellicano, Valeria Carnazzo, Umberto Basile, Edoardo Rosato, Antonietta Gigante, Scleroderma Renal Study Group

Kidney involvement in Systemic Sclerosis (SSc) is primarily due to vasospasm induced by renal Raynaud's phenomenon, leading to hypoxia, impaired angiogenesis and microvascular dysfunction. Renal... more

Apixaban and the improved psychologic profile in frailty and disability. Myth or reality?

18 March 2025
Author(s): Stefano Fumagalli, Giuseppe Di Pasquale, Giulio Molon, Giancarlo Agnelli, Niccolò Marchionni, APULEIO Study Investigators

We thank Hung and Chao for their interest in our work [1]. Their letter [2] allowed us to specify some relevant aspects about APULEIO (Treatment satisfaction of Italian patients undergoing Apixaban... more

Serum angiopoietin-like protein 4 levels correlate with hypertriglyceridemia and renal function decline in pediatric patients with lupus nephritis

17 March 2025
Author(s): Wangqiu Gong, Guanyu Li, Di Lu, Ming Liu, Xia Gao

Lupus nephritis (LN) is the most common complication of systemic lupus erythematosus (SLE), with up to 70 % of pediatric SLE patients experiencing kidney involvement, and LN also aggravates the... more

Atrial fibrillation ablation versus medical therapy in heart failure with preserved ejection fraction

14 March 2025
Author(s): Xin Liu, Wulamiding Kaisaier, Kai Chen, Beibei Yu, Wengen Zhu

Heart failure with preserved ejection fraction (HFpEF) is a multifaceted and increasingly prevalent clinical syndrome that presents significant challenges in both diagnosis and management. Its... more

Why did it take forty years to uncover long-term fluoroquinolone associated toxicities?

14 March 2025
Author(s): Charles L Bennett, Linda Martin, Gretchen LeFever Watson, Steven T Rosen, David Aboulafia, SONAR Pharmacovigilance Group

Since fluoroquinolones (FQs) were introduced in 1986, 1 billion courses have been administered [1]. Safety announcements have been disseminated since 2016 in the United States (US), European Union (... more

Diastolic blood pressure variability predicts adverse outcomes in stabilized acute heart failure patients

13 March 2025
Author(s): Hyung Joon Joo, Soon Jun Hong, Cheol Woong Yu, Yong Hyun Kim, Eung Ju Kim

Blood pressure variability; heart failure; Cardiovascular outcome; Diastolic blood pressure

Building on the UTILY Study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections. Author's reply

8 March 2025
Author(s): Lorenzo Onorato, Margherita Macera, Caterina Monari, Nicola Coppola

Dear Editor,

More on peripheral artery disease and air pollution. Author's reply

7 March 2025
Author(s): Chiara Di Blasi, Alberto Maria Settembrini, Massimo Stafoggia, Matteo Renzi, Pier Mannuccio Mannucci

Dear Editor,

Critical considerations for sodium bicarbonate therapy in metabolic acidosis: Addressing confounding factors and methodological limitations

5 March 2025
Author(s): Danyang Liu

I recently read the paper by Tong et al., which explores the clinical effects of sodium bicarbonate (SOB) therapy in metabolic acidosis, focusing on the interaction between baseline chloride levels... more

Utilizing D-dimer levels for predicting survival probability in unplanned hospital admissions: Insights from a 5-year nationwide population-based register study

4 March 2025
Author(s): Mikkel Brabrand, Marianne Fløjstrup, Søren Bie Bogh, Tim Cooksley, Christian Hans Nickel

Although the most common clinical use of D-dimer measurements is to rule out thromboembolic disease [1], it is also elevated in several other serious illnesses and raised levels are associated with a... more

Evidence that adequate provision of vitamin D reduces cardiovascular disease risks

3 March 2025
Author(s): William B. Grant, Barbara J. Boucher

We read with interest the clinical insight by Cimminiello regarding the role of vitamin D and cardiovascular risk [1]. He dismissed the epidemiological evidence that vitamin D deficiency is... more

Why doesn't sepsis rhyme with Internal Medicine?

26 February 2025
Author(s): Chiara Casarsa, Filippo Mearelli, Alessio Nunnari, Francesca Spagnol, Stefano Di Bella

I am writing to share some reflections on the challenges that internists face in the management of sepsis, a complex and multifactorial condition requiring a multidisciplinary approach. Despite the... more

Effect of newer glucose-lowering medications on chronic obstructive pulmonary disease exacerbations among individuals with type 2 diabetes

22 February 2025
Author(s): Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, Ricardo Gómez-Huelgas

Type 2 diabetes mellitus (T2D) and chronic obstructive pulmonary disease (COPD) are prevalent chronic conditions that frequently coexist, contributing to significant morbidity and healthcare burden... more

Non-statistical significance and clinical relevance: Are we chasing shadows in the air pollution-peripheral artery disease debate?

21 February 2025
Author(s): Stephan Peronard Mayntz, Kasper Emil Rosenbech

The impact of air pollution on cardiovascular diseases has been a subject of extensive research, with compelling evidence linking long-term exposure to pollutants such as particulate matter (PM2.5),... more

Gut dysbiosis and leaky gut syndrome in moderately impaired amyotrophic lateral sclerosis patients

20 February 2025
Author(s): Laura Comini, Davide Antonio Di Pietro, Adriana Olivares, Enrica Bertella, Michele Vitacca

Dear Editor,

Hemoglobin levels for the diagnosis of polycythemia vera: How high is high enough?

17 February 2025
Author(s): Ugur Koca, Enes Seyda Sahiner, Ozge Soyer Kosemehmetoglu, Tekin Guney, Betul Erismis

The World Health Organization (WHO) diagnostic criteria for Polycythemia Vera (PV), initially published in 2001 and 2008, were last revised in 2016. According to these criteria, evaluation for PV is... more

Evolution of care pathways in clinical practice guidelines for heart failure

17 February 2025
Author(s): Quirós-López R, Estupiñán-Romero F, Millán-Ortuondo E, Bernal-Delgado E, Jiménez-García N

In the context of the increasing complexity of patients with heart failure (HF) and the rapid expansion of available therapies, clinical practice guidelines (CPGs) have become indispensable for... more

Direct oral anticoagulants guided by CHA2DS2-VASc stratification for stroke prevention in patients with device-detected atrial fibrillation

15 February 2025
Author(s): Zhengbiao Xue, Song Liao, Haiye Fan, Yu Shen, Zhi Nie

Atrial fibrillation (AF) significantly increases stroke risk, with affected individuals having a fivefold higher likelihood compared to the general population. Oral anticoagulation (OAC),... more

Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients

14 February 2025
Author(s): Claudia Stöllberger, Raphael Wilfing, Josef Finsterer, Birke Schneider

Sodium-Glucose Cotransporter2-inhibitors (SGLT2i) were developed for treating diabetic patients. Empagliflozin and dapagliflozin, frequently prescribed SGLT2i, are now also recommended for... more

Factor XI/XIa inhibitors versus direct oral anticoagulants in atrial fibrillation

9 February 2025
Author(s): Shan Zeng, Wulamiding Kaisaier, Chen Liu, Wengen Zhu

Dear Editor,

Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome. Author's reply

8 February 2025
Author(s): Luca Arcari, Giacomo Tini, Beatrice Musumeci, Emanuele Barbato, Luca Cacciotti

We thank García-Martí et al. for the interest in our study recently published in the European Journal of Internal Medicine [1], and here we provide further analysis following their stimulating... more

Rising ischemic stroke-related mortality among young adults in the United States: Insights from CDC WONDER

8 February 2025
Author(s): Usama Qamar, Farhan Naeem, Maaz Asif, Waleed Qamar, Eisha Mazhar

Ischemic Stroke-related mortality among young adults aged 25–64 years in the United States from 1999 to 2020.

Bedside CEUS: A feasible option to consider

6 February 2025
Author(s): Andrea Boccatonda, Alice Brighenti, Valeria Tiraferri, Rossella Loiacono, Carla Serra

Contrast-enhanced ultrasound (CEUS) is widely used for assessing the perfusion of specific organs or lesions. While CEUS has been extensively studied in outpatient settings, its use as a bedside... more

Tecovirimat and mpox: A regulatory balancing act between hope, hurdles, and high-risk populations

3 February 2025
Author(s): John G. Rizk, Giuseppe Lippi, Brandon M. Henry, Kin Israel Notarte, Youssef Rizk

Tecovirimat (marketed as TPOXX in the United States and other regions) is an antiviral drug that targets orthopoxviruses, including smallpox, monkeypox (now mpox), and cowpox. Tecovirimat inhibits... more

Disability and caregivers in Italy: Results from an online survey

3 February 2025
Author(s): Sergio Harari, Antonella Caminati, Luigi Ripamonti, Paolo Marveggio, Pier Mannuccio Mannucci

Disability is a condition with a significant impact on the quality of life of patients, on families who are often acting as their caregivers and on the society at large, with important economic... more

Building on the UTILY Study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections

1 February 2025
Author(s): Heng Xiao, Wen Xiao, Xinmin Deng

We have carefully reviewed the article by Onorato et al., published in the European Journal of Internal Medicine [1]. The study provides important insights into the prevalence of multidrug-resistant... more

Frailty, disability and patient-reported outcomes in apixaban users

30 January 2025
Author(s): Stefano Fumagalli, Giuseppe Di Pasquale, Giulio Molon, Giancarlo Agnelli, Niccolò Marchionni, APULEIO Study Investigators

atrial fibrillation (AF) is the arrhythmia most frequently diagnosed in older patients with a prevalence higher than 10 % in subjects ≥70 years [1]. The incidence of venous thromboembolism (VTE),... more

Mortality in the first 24 hours after admission in the intensive care unit

30 January 2025
Author(s): Rita Pinto Medeiros, Rita Pereira, Carla Teixeira

Dear Editor,

Obesity in Europe: Less impact on chronic diseases thanks to internists?

20 January 2025
Author(s): Livio Garattini, Antonino Mazzone

Defined by the WHO as the ‘new epidemic of the 21st century’, nowadays obesity has become an international public health issue [1], since it can cause a wide range of diseases and a growth in both... more

Telerehabilitation in patients with long COVID-19 syndrome

20 January 2025
Author(s): Shige Li, Wenbo Dong, Bing Dai, Wei Wang, Wei Tan

Post-acute sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease (COVID-19), known as long COVID syndrome, is defined as new symptoms that occur beyond 3 months after... more

Trends in industry-sponsored research payments to internist principal investigators

17 January 2025
Author(s): Aurora J. Grutman, Zeyad Hammadeh, Joseph G. Cheaib, Evans K.H. Brown, Misop Han

In the United States, the Physician Payments Sunshine Act, passed by Congress as part of the 2010 Affordable Care Act, has brought greater transparency to financial relationships between industry and... more

Refining insights into rheumatoid arthritis-associated liver dysfunction: Opportunities for methodological advancements and clinical implications

13 January 2025
Author(s): Zhongxing Liu, Peng Guo, Guohong Xiang, Lincheng Duan

We read with great interest the article by Arias-de la Rosa et al., published in the European Journal of Internal Medicine [1]. This study provides valuable evidence that patients with rheumatoid... more

Vaginal self-sampling for human papillomavirus to improve cervical cancer screening in patients with immune-mediated inflammatory diseases

12 January 2025
Author(s): Tiphaine Goulenok, Chrystelle François, Valentine Marie Ferré, Arthur Mageau, Karim Sacré, APOSY Study Group

Dear Editor,

Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome

12 January 2025
Author(s): Gonzalo García-Martí, Ravi Vazirani, Hernán Mejía-Rentería, Iván J. Núñez-Gil

Dear Editor,

Rituximab in Immune-mediated thrombotic thrombocytopenic purpura

2 January 2025
Author(s): Jie Li, Jiashuo Guo, Ruirui Yuan, Liying Xue

Thrombotic thrombocytopenic purpura (TTP) is a rare and potentially fatal thrombotic microangiopathy, defined by a mechanical hemolytic anemia, severe thrombocytopenia, and visceral ischemia due to... more

Refining the understanding of cardiovascular risk following COPD exacerbations: Opportunities for stratified and multidisciplinary approaches

24 December 2024
Author(s): Rujian Yu, Lamei Zou

We have carefully reviewed the article by Calabria et al., published in the European Journal of Internal Medicine [1]. This study, based on a comprehensive database analysis, highlights the... more

Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients

24 December 2024
Author(s): Yinfang Wu, Qi Zhao

The study by Paiva and colleagues [1] provides valuable insights into intra-abdominal infections (IAI) in immunocompromised intensive care unit (ICU) patients, highlighting similarities and... more

Analysis of “characteristics of familial mediterranean fever disease after 65 years of age”

18 December 2024
Author(s): Kazim Besirli

I have read the article “Characteristics of Familial Mediterranean fever (FMF) after 65 years of age” with great interest. The study provides valuable insights into the clinical features and... more

Hypertension – a global problem requiring a comprehensive approach

12 December 2024
Author(s): Agnieszka Zalewska, Anna Litwińska-Kmiecik, Alicja Wiśniewska

We read with great interest a recently published study by Rikuta Hamaya, Molin Wang, Ellen Hertzmark, et al. regarding modifiable lifestyle factors in the primordial prevention of hypertension [1].... more

Risk for hospital-treated infections in dermatitis herpetiformis and coeliac disease

12 December 2024
Author(s): Camilla Pasternack, Matti Karppelin, Kaisa Hervonen, Katri Kaukinen, Teea Salmi, Celiac Disease Study Group

Dear Editor,

Risk of injurious falls in older people with atrial fibrillation

10 December 2024
Author(s): Anna Litwińska-Kmiecik, Agnieszka Zalewska

Dear editor,

Use of betablockers in post-myocardial infarction patients in a real-world setting

9 December 2024
Author(s): Marta Baviera, Anna Zanovello, Luisa Ojeda-Fernández, Mauro Molteni, Claudio Cimminiello

For many years, the main guidelines have been recommending the use of betablocker therapy in patients after myocardial infarction (MI) [1,2]. This recommendation entails a high class and grade for... more

High-risk allogeneic stem cells transplantation in advanced age patients with uncontrolled sickle cell disease

8 December 2024
Author(s): Frederic Garban, Caroline Makowski, Claude Eric Bulabois, Laurence Bouillet, Mathieu Meunier

Sickle cell disease (SCD) is a recessive monogenic disease where a single nucleotide mutation of the HBB gene, encoding the β-globin chain of hemoglobin (Hb), leads to the synthesis of HbS.... more

Seasonality of diabetic ketoacidosis in hot climate

28 November 2024
Author(s): Fahmi Abu Ghalion, Mai Ofri, Victor Novack, Lena Novack

Diabetic ketoacidosis (DKA) is a life-threatening condition arising from an absolute or relative insulin deficiency, leading to hyperglycemia and ketone body accumulation in the blood with metabolic... more

Validating ChatGPT's role in systematic reviews and meta-analyses: A case study on GLP-1 receptor agonists and all-cause mortality

28 November 2024
Author(s): Lefteris Teperikidis, Paschalis Karakasis, Dimitrios Patoulias, Aristi Boulmpou, Dimitrios Kouzoukas, AIMES – AI for Meta-Analysis and Evidence Synthesis

Dear Editor,

Refining metabolic health assessment in inflammatory bowel disease risk prediction

29 October 2024
Author(s): Yinfang Wu, Weixing Xu

Mi et al.'s investigation [1], drawing upon the United Kingdom (UK) Biobank resource, delves into the interplay between metabolic health and genetic predisposition to inflammatory bowel disease (IBD... more

Original Article

Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism

18 April 2025
Author(s): Maria Cristina Vedovati, Andrés J. Muñoz Martín, Michela Giustozzi, Paula Jimenez-Fonseca, Cecilia Becattini, Maria Purificación Martínez del Prado, Francesco Dentali, Menno V. Huisman, Alexander T. Cohen, Rupert Bauersachs, Alberto Carmona-Bayonas, Giancarlo Agnelli

Cancer associated venous thromboembolism (CAT) has a high risk of recurrence and treatment-emergent bleeding [1–4]. The identification of risk factors for venous thromboembolic (VTE) recurrence and... more

Mortality and causes of death in patients hospitalized with hyponatremia – a propensity matched cohort study

15 April 2025
Author(s): Buster Mannheimer, Jonatan D. Lindh, Issa Issa, Mikael Andersson Franko, Henrik Falhammar, Jakob Skov

Hyponatremia is the commonest electrolyte imbalance, affecting more than one in 10 patients admitted to hospital [1]. Women, elderly, and individuals with comorbid burdens are generally at greater... more

The impact of sensitization patterns on COPD severity and exacerbations: Insights from a case-control and longitudinal study

12 April 2025
Author(s): Meropi Karakioulaki, Caroline Maria Berkemeier, Leticia Grize, Ingmar Heijnen, Stergios A. Polyzos, Antonis Goulas, Michael Tamm, Daiana Stolz

Common to several allergic diseases is the generation of immunoglobulin E (IgE) by plasma cells, when exposed to an innocuous antigen [1]. Upon initial exposure to allergen, antigen presenting cells... more

Performance and costs of rule-out protocols for acute aortic syndromes: analysis of pooled prospective cohorts

11 April 2025
Author(s): Paolo Bima, Peiman Nazerian, Christian Mueller, Matteo Castelli, Elisa Capretti, Alexandre de Matos Soeiro, Alessandro Cipriano, Giorgio Costantino, Simone Vanni, Bernd A. Leidel, Beat A. Kaufmann, Adi Osman, Marcello Candelli, Nicolò Capsoni, Wilhelm Behringer, Giovanni Ascione, Tatiana de Carvalho Andreucci Torres Leal, Lorenzo Ghiadoni, Emanuele Pivetta, Enrico Lupia, Fulvio Morello, PROFUNDUS and ADvISED Study Investigators

Acute aortic syndromes (AASs) are life-threatening cardiovascular emergencies affecting 5–15 individuals per 100,000 person-years [1]. They are characterized by dissection, hematoma, ulceration or... more

Diagnostic accuracy of emergency department ECGs in hyperkalemia detection: A cross-sectional study

9 April 2025
Author(s): Luca Ünlü, Frank-Peter Stephan, Florian N. Riede, Annette Christine Mettler, Gilles Dutilh, Gioele Capoferri, Tito Bosia, Christian Sticherling, Roland Bingisser, Christian H. Nickel

Hyperkalemia is a common condition in Emergency Departments (EDs) and can be fatal [1–3]. Hyperkalemia reduces conduction velocity and renders myocytes refractory to excitation. Dysrhythmias are... more

Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients

8 April 2025
Author(s): Inès Elhani, Laure Calas, Farah Bejar, Bruno Fautrel, Laurence Pieroni, Véronique Hentgen, Philippe Mertz, Stéphane Mitrovic, Marion Delplanque, Léa Savey, Sophie Georgin-Lavialle

Auto-inflammatory diseases (AIDs) are defined as dysfunction of innate immunity [1]. They can involve different pathways. Familial Mediterranean fever (FMF), Still's disease, Mevalonate Kinase... more

Isolated joint involvement in Whipple's disease: a cohort study

8 April 2025
Author(s): Victor Eiferman, Alice Chanteloup, Jean Christophe Lagier, Xavier Puéchal

Whipple's disease was first described in 1907 by George Hoyt Whipple. Significant microbiological advances have since revolutionised our understanding of the disease, first with molecular biology and... more

Intermediate Care Units in Internal Medicine

4 April 2025
Author(s): Ciro Canetta, Silvia Accordino, Fabiola B. Sozzi

A cornerstone of the reorganization challenge of hospital systems has been provided by the Progressive Patient Care (PPC) model [1], lying on the concept of pooling patients around the acuity of... more

Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss

1 April 2025
Author(s): Federica Tambaro, Antonietta Gigante, Carmen Gallicchio, Chiara Pellicano, Cesarina Ramaccini, Roberta Belli, Maria Ludovica Gasperini-Zacco, Edoardo Rosato, Maurizio Muscaritoli

Systemic sclerosis (SSc) is a rare, complex autoimmune disease characterized by vasculopathy and fibrosis of the skin and internal organs. Clinical manifestations of SSc are the result of the... more

The role of an intermediate care unit in reducing intensive care unit admissions and improving patient outcomes in internal medicine: A quasi-experimental study

28 March 2025
Author(s): Gianni Turcato, Arian Zaboli, Paolo Ferretto, Lucia Filippi, Daniela Milazzo, Marta Parodi, Michael Maggi, Alessandro Cipriano, Massimo Marchetti, Christian Josef Wiedermann, Lorenzo Ghiadoni

The optimal management of non-intensive critical patients remains a debated topic. This debate is further complicated by the fact that Intensive Care Units (ICUs) bed availability is regulated by... more

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

27 March 2025
Author(s): Maria Grau-Perez, Olga Martinez-Arroyo, Marta Rubia-Martinez, Ana Flores-Chova, Zulema Rodriguez-Hernandez, Pablo Fernández-Navarro, Anna Gonzalez-Neira, Maria Rosario Alonso, Guillermo Pita, Silvia Pineda, Juan Carlos Martin-Escudero, Ana Ortega, Josep Redon, Maria Tellez-Plaza, Raquel Cortes

The potential use of microRNAs (miRNAs), endogenous RNAs of approximately 22 nucleotides that play a regulatory role by targeting mRNAs for translational excision or repression [1,2], has gained... more

Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients

25 March 2025
Author(s): Giulia Bandini, Corrado Campochiaro, Gabriele Ciuti, Domenico Baccellieri, Vincenzo Ardita, Silvia Bellando Randone, Khadija El Aoufy, Dilia Giuggioli, Martina Orlandi, Lorenzo Dagna, Roberto Chiesa, Marco Matucci Cerinic, Alberto Moggi Pignone

Systemic sclerosis (SSc) is an autoimmune rheumatic disease where vasculopathy is one of the main hallmarks, and the gastrointestinal (GI) tract is one of the most affected systems [1,2]. In fact,... more

Excess mortality of critically ill patients aged ≥90 years in intensive care units: A retrospective cohort study

25 March 2025
Author(s): Jan Frederic Weller, Kevin Roedl, Rikus Daniels, Pauline Theile, Jakob Müller, Frederik Peters, Claudia Lengerke, Carsten Bokemeyer, Liesbeth de Wreede, Stefan Kluge, Maximilian Christopeit

We live in an aging society, which is foremost caused by increasing life expectancy, next other factors. In concordance, at least the sheer number of older patients increases, too. When those older... more

R202Q homozygosity of Mediterranean fever gene is associated with atypical clinical phenotype of familial Mediterranean fever

21 March 2025
Author(s): Dimitrios Sagris, Christina Antoniadou, Nikolaos K. Gatselis, Efstratios Gavriilidis, Vasileios Papadopoulos, Sarah Georgiadou, Stella Gabeta, Victoria Tsironidou, Konstantinos P. Makaritsis, Panagiotis Skendros, Eirini I. Rigopoulou, Konstantinos Ritis, George N. Dalekos

Autoinflammatory disorders represent a heterogenous group of genetic or acquired systemic diseases characterized by febrile episodes and chronic inflammation, due to dysregulation of innate immunity... more

Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype

19 March 2025
Author(s): Ruggiero Mascolo, Maddalena Alessandra Wu, Silvia Berra, Matteo Vidali, Massimo Pancrazi, Lucia Trotta, Elisa Ceriani, Enrica Negro, Lisa Serati, Luisa Carrozzo, Elisa Calabrò, Ferruccio Ceriotti, Alessandro Andreis, Valentino Collini, Massimo Imazio, Antonio Brucato

Idiopathic recurrent acute pericarditis (IRAP) significantly affects patients’ quality of life, imposing a psychosocial burden, alongside risks of complications, treatment-related adverse effects,... more

Gendered social determinants of health and risk of major adverse outcomes in atrial fibrillation

9 March 2025
Author(s): Jonathan Houle, Marco Proietti, Valeria Raparelli, Clare L Atzema, Colleen M Norris, Michal Abrahamowicz, Gregory YH Lip, Giuseppe Boriani, Louise Pilote

The global population is aging and the burden of atrial fibrillation (AF) is expected to rise sharply over the next decades [1,2]. Beyond a fivefold increase in stroke risk, individuals with AF... more

Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure

7 March 2025
Author(s): Roberto Tonelli, Giulia Bruzzi, Riccardo Fantini, Luca Tabbì, Antonio Moretti, Francesco Livrieri, Ivana Castaniere, Stefania Cerri, Daniele Puggioni, Federico Guidotti, Gianluca Bellesia, Alessandro Marchioni, Enrico Clini

In recent years, particularly following the COVID-19 pandemic, there has been increasing interest in non-invasive respiratory support (RS) to manage the acute hypoxemic respiratory failure (AHRF) [1–... more

Assessment of cardiovascular, thromboembolic and cancer risk in patients eligible for treatment with Janus Kinase inhibitors: The JAK-ERA multidisciplinary consensus

20 February 2025
Author(s): Lorenzo Dagna, Alessia Alunno, Nicola Farina, Giancarlo Agnelli, Claudio Borghi, Roberto Caporali, Antonio Costanzo, Silvio Danese, Filippo De Braud, Gian Domenico Sebastiani, Carlo Maurizio Montecucco

Janus kinase inhibitors (JAKi), a class of targeted synthetic disease-modifying antirheumatic drugs, have significantly impacted clinical practice in the treatment of various autoimmune and... more

Promoting women's careers in life science and medicine: A position paper from the “International Women in Intensive Medicine” network

15 February 2025
Author(s): Olfa Hamzaoui, Florence Boissier, Carla Teixera, Luciana Mascia, Irene Aragao, Sahar Bahrami, Maria Cruz Martin Delgado, Jannicke Mellin-Oslen, Jordi Rello, Francesca Rubulotta, iWIN network members in annex 1

It is well-established that women are underrepresented in leadership positions [1], undervalued in their academic careers, and experience gender discrimination in scientific and healthcare... more

Hypertensive heart disease in older patients: considerations for clinical practice

15 February 2025
Author(s): Miguel Camafort, Alexandros Kasiakogias, Enrico Agabiti-Rosei, Stefano Masi, Panagiotis Iliakis, Athanase Benetos, Jin-Ok Jeong, Hae-Young Lee, Maria Lorenza Muiesan, Isabella Sudano, Costas Tsioufis, European Society of Hypertension Working Group on Hypertension and the Heart

Appropriate blood pressure (BP) control remains the main therapeutic strategy to address the adverse sequelae of hypertension irrespective of a patient's age [1]. A patient group that is continuously... more

Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study

13 February 2025
Author(s): Joost Boeckmans, Linnea Widman, Ying Shang, Rickard Strandberg, Axel Wester, Jörn M Schattenberg, Hannes Hagström

Patients with a chronic liver disease often develop liver cirrhosis after a certain time if their disease is not appropriately managed, and cirrhosis was the cause of death in 2.4 % of all deaths... more

Clinical familial hypercholesterolemia - factors influencing diagnosis and cardiovascular risk in the general population

13 February 2025
Author(s): Frida Toft-Nielsen, Frida Emanuelsson, Børge G Nordestgaard, Marianne Benn

Heterozygous familial hypercholesterolemia (FH) is an autosomal, dominant disorder of lipoprotein metabolism. The disease is estimated to affect 1:250 of individuals in Western populations [1–3].... more

Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)

11 February 2025
Author(s): Sofia-Panagiota Giannakopoulou, Fotios Barkas, Christina Chrysohoou, Evangelos Liberopoulos, Petros P. Sfikakis, Christos Pitsavos, Costas Tsioufis, Demosthenes Panagiotakos

In the mid-2010s, after four decades of consistent decline, the mortality rate from heart disease began to show an increasing trend. This shift was largely attributed to the growing obesity epidemic... more

Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis

11 February 2025
Author(s): Marco Canepa, Gianluca Anastasia, Pietro Ameri, Rocco Vergallo, Christopher M. O'Connor, Gianfranco Sinagra, Italo Porto

Heart failure (HF) is a major cause of cardiovascular (CV) morbidity and mortality in developed countries with rising prevalence due to the aging of the population, the poor control of CV risk... more

Advancing women's health with a pioneering implant to treat breast cancer related lymphedema

11 February 2025
Author(s): L. Mazzolai, V. Triacca, M.J. Brochu-Vez, V. Boucard, M. Aberle, V. Chaplet, V. Ferrari, S. Déglise, M. Pisano, S. Staubli

Lymphedema (LE) is a frequent, but often overlooked condition, with secondary LEs accounting for approximately 82.5% of cases [1]. It typically arises from lymphatic vessel damage or obstruction... more

High-flow nasal oxygen therapy in patients with hypercapnic respiratory failure: A systematic review and meta-analysis

8 February 2025
Author(s): Lili Guan, Jianyi Niu, Qiaoyun Huang, Shanshan Zha, Zhenfeng He, Jieying Hu, Shengchuan Feng, Luqian Zhou, Rongchang Chen

Noninvasive ventilation (NIV) has been used to treat acute respiratory failure for more than 30 years, and it is undoubtedly one of the most important advances in respiratory support [1]. With the... more

Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study

31 January 2025
Author(s): Elena Olmastroni, Julius L. Katzmann, Federica Galimberti, Ulrich Laufs, Alberico L. Catapano

Lipoprotein(a) [Lp(a)] is an apoB-containing lipoprotein bound to a hydrophilic, highly glycosylated protein called apolipoprotein(a) [apo(a)] [1]. Apo(a) is encoded by the LPA gene, and Lp(a)... more

Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis

29 January 2025
Author(s): Edoardo Pirera, Domenico Di Raimondo, Lucio D'Anna, Antonino Tuttolomondo

Chronic obstructive pulmonary disease (COPD) is primarily a respiratory condition characterized by irreversible airflow limitation and multiple debilitating symptoms, including dyspnea, cough, and... more

Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: A meta-analysis of randomized controlled trials

21 January 2025
Author(s): Renzo Laborante, Donato Antonio Paglianiti, Emiliano Bianchini, Mattia Galli, Josip Andelo Borovac, Gianluigi Savarese, Giuseppe Patti, Domenico D'Amario

Acute heart failure (HF) is a clinical syndrome with multiple aetiologies, among which acute coronary syndrome constitutes one of the most frequent precipitating factors, especially in developed... more

What is the impact of thiamine deficiency on cognitive function in patients with alcohol use disorder? – A systematic review

15 January 2025
Author(s): Joana Teixeira, Inês Pereira, Miguel Castanho, Frederico Simões do Couto

Cognitive impairments, frequently observed in Alcohol Use Disorder (AUD) patients, range from severe memory impairment with other cognitive functions relatively preserved seen in Korsakoff's Syndrome... more

Effects of population-based screening for atrial fibrillation on quality of life

12 January 2025
Author(s): Emilie Katrine Kongebro, Christian Kronborg, Lucas Yixi Xing, Ketil Jørgen Haugan, Claus Graff, Søren Højberg, Morten S Olesen, Derk Krieger, Axel Brandes, Lars Køber, Jesper Hastrup Svendsen, Søren Zöga Diederichsen

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, and mortality [1]. Many cases of AF remain undetected due to no or... more

Adverse effects of late sleep on physical health in a large cohort of community-dwelling adults

31 December 2024
Author(s): Renske Lok, Lara Weed, Joseph Winer, Jamie M. Zeitzer

Human health is influenced by a myriad of factors, including genetics, environment, and behavior. One behavior that has received significant recent attention is the impact of sleep on human health.... more

Review Article

A physico-chemical explanation for the litho-protective effects of obeticholic acid in low phospholipid-associated cholelithiasis

16 April 2025
Author(s): Karel J. van Erpecum, Piero Portincasa, Gerard P. van Berge Henegouwen, Antonio Moschetta

Prevalence of gallstones in the adult European population is ̴20 % (mostly cholesterol stones in the gallbladder). Obesity, metabolic syndrome, type 2 diabetes, female sex, pregnancy, multiparity and... more

Cancer genetic profile and risk of thrombosis

11 April 2025
Author(s): Francisco J. Pelegrín-Mateo, Carmen Beato Zambrano, Elena Brozos Vázquez, Ignacio García Escobar, Andrés Muñoz Martín

The occurrence of a venous thromboembolic event (VTE) among cancer patients has been rising steadily by up to threefold in some series with respect to the general population [1–3]. This risk is... more

Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence

22 March 2025
Author(s): Mehmet Kanbay, Lasin Ozbek, Mustafa Guldan, Sama Mahmoud Abdel-Rahman, Arif E. Narin, Alberto Ortiz

The rapid rise in ultra-processed foods (UPFs) has become a significant public health concern worldwide [1]. UPFs are typically high in unhealthy fats, refined sugars, refined carbohydrates, sodium,... more

Tularemia for clinicians: An up-to-date review on epidemiology, diagnosis, prevention and treatment

19 March 2025
Author(s): Roberta Maria Antonello, Andrea Giacomelli, Niccolò Riccardi

After its first description in the 1910s in the Tulare county of California associated with a massive die off of ground squirrels and initially misdiagnosed with bubonic plague, by 1935 tularemia had... more

How to promote healthy aging across the life cycle

19 March 2025
Author(s): Camilla Cocchi, Maria Beatrice Zazzara, Elena Levati, Riccardo Calvani, Graziano Onder

The global population of older adults has grown rapidly in recent years. In Europe, this percentage ranks among the highest, with 21.3 % of the population aged over sixty-five [1]. Projections... more

Comprehensive management of pneumonia in older patients

27 February 2025
Author(s): Alain Putot, Nicolas Garin, Jordi Rello, Virginie Prendki, European Study Group of Infections in the Elderly Patients (ESGIE).

Pneumonia is a bacterial, viral, fungal, or parasitic infection of lung parenchyma, resulting in significant local and systemic inflammation. Pneumonia is the leading infectious cause of... more

Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes

6 February 2025
Author(s): Roberta Gualtierotti

It is widely recognized that sex and gender interact with factors such as genetic background, ethnicity, socioeconomic status, disability, and age, thus influencing health status and disease. The... more

Beyond creatinine: New methods to measure renal function?

31 January 2025
Author(s): M. Salman Sheikh, Kianoush B. Kashani

The kidneys play a central role in maintaining the body's homeostasis, performing a wide range of vital functions. They eliminate unnecessary and potentially toxic metabolic waste products, such as... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness